EZZ Secures Five-Year Sales Deal with Pinehills for AU$15 million

Highlights:

• EZZ signed a five-year sales agreement with Pinehills (Hong Kong) Limited.
• Pinehills will purchase EZZ products worth at least AU$15 million in the first year.
• Annual purchase volumes will increase by a minimum of 10% each year over the agreement term.
• The agreement expands EZZ’s distribution to China, Vietnam, and other Southeast Asian markets.

EZZ Life Science Holdings Limited (ASX: EZZ) has announced a significant five-year sales agreement with Pinehills (Hong Kong) Limited. This deal ensures Pinehills will purchase a minimum of AU$15 million worth of EZZ-branded products in the first year, with a mandatory annual increase of at least 10%. This partnership will significantly enhance EZZ's market presence in key regions, including China and Vietnam. Chairman Glenn Cross expressed confidence in the agreement, highlighting its role in EZZ’s growth and market expansion.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com